BeOne Medicines Ltd. (ONC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 600M 1.2B 1.8B Q3 '21: 206.4M Q4 '21: 214M Q1 '22: 306.6M Q2 '22: 341.6M Q3 '22: 387.6M Q4 '22: 380.1M Q1 '23: 447.8M Q2 '23: 595.3M Q3 '23: 781.3M Q4 '23: 634.4M Q1 '24: 751.7M Q2 '24: 929.2M Q3 '24: 1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.3B Q3 '25: 1.4B Q4 '25: 1.5B Q1 '26: 1.5B Q2 '26: 1.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 600M 1.2B 1.8B Q1 '23: 366M Q2 '23: 499.3M Q3 '23: 685M Q4 '23: 528.6M Q1 '24: 626.7M Q2 '24: 791M Q3 '24: 831.1M Q4 '24: 967.3M Q1 '25: 952.3M Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.4B Q1 '26: 1.3B Q2 '26: 1.5B Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-600M -400M -200M 0 200M 400M 600M Q3 '21: -462.3M Q4 '21: -571.7M Q1 '22: -443.3M Q2 '22: -439.4M Q3 '22: -438.4M Q4 '22: -468.6M Q1 '23: -371.3M Q2 '23: -318.7M Q3 '23: -134M Q4 '23: -383.8M Q1 '24: -261.3M Q2 '24: -107.2M Q3 '24: -120.3M Q4 '24: -79.4M Q1 '25: 11.1M Q2 '25: 87.9M Q3 '25: 163.1M Q4 '25: 185M Q1 '26: 249.9M Q2 '26: 325M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-750M -500M -250M 0 250M 500M 750M Q3 '21: -438.1M Q4 '21: -590.7M Q1 '22: -435.2M Q2 '22: -565.7M Q3 '22: -557.6M Q4 '22: -445.3M Q1 '23: -348.4M Q2 '23: -381.1M Q3 '23: 215.4M Q4 '23: -367.6M Q1 '24: -251.2M Q2 '24: -120.4M Q3 '24: -121.3M Q4 '24: -151.9M Q1 '25: 1.3M Q2 '25: 94.3M Q3 '25: 124.8M Q4 '25: 66.5M Q1 '26: 227.4M Q2 '26: 237M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 35M 70M 105M Q4 '18: 9.2M Q1 '19: 15.3M Q2 '19: 17.8M Q3 '19: 20.1M Q4 '19: 18M Q1 '20: 14.1M Q2 '20: 14.3M Q3 '20: 21.1M Q4 '20: 21.1M Q1 '21: 32.7M Q2 '21: 36.3M Q3 '21: 47.4M Q4 '21: 48.5M Q1 '22: 65.2M Q2 '22: 71.2M Q3 '22: 76.5M Q4 '22: 73.5M Q1 '23: 81.8M Q2 '23: 96M Q3 '23: 96.3M Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23

Operating Cash Flow Quarterly

-600M -400M -200M 0 200M 400M 600M Q3 '21: -495.7M Q4 '21: -507.8M Q1 '22: -236.6M Q2 '22: -380M Q3 '22: -561.9M Q4 '22: -318.2M Q1 '23: -563.8M Q2 '23: -293.9M Q3 '23: -78.2M Q4 '23: -221.6M Q1 '24: -308.6M Q2 '24: -95.6M Q3 '24: 188.4M Q4 '24: 75.2M Q1 '25: 44.1M Q2 '25: 263.6M Q3 '25: 402.6M Q4 '25: 417.3M Q1 '26: 201.3M Q2 '26: 462.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-750M -500M -250M 0 250M 500M 750M Q3 '21: -562.8M Q4 '21: -622.8M Q1 '22: -281.7M Q2 '22: -430.2M Q3 '22: -670.6M Q4 '22: -439.5M Q1 '23: -689.4M Q2 '23: -415.4M Q3 '23: -236M Q4 '23: -378.6M Q1 '24: -465.1M Q2 '24: -205.5M Q3 '24: 54.7M Q4 '24: -17.3M Q1 '25: -12.3M Q2 '25: 219.8M Q3 '25: 354.5M Q4 '25: 379.8M Q1 '26: 160.5M Q2 '26: 435.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 600M 1.2B 1.8B Q1 '20: 1B Q2 '20: 1B Q3 '20: 1.1B Q1 '21: 1.3B Q2 '21: 1.2B Q3 '21: 1.2B Q1 '22: 1.3B Q2 '22: 1.3B Q3 '22: 1.3B Q1 '23: 1.4B Q2 '23: 1.4B Q3 '23: 1.4B Q1 '24: 1.4B Q2 '24: 1.4B Q3 '24: 1.4B Q1 '25: 1.4B Q2 '25: 1.5B Q3 '25: 1.5B Q1 '26: 1.5B Q2 '26: 1.5B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '21: -1.11 Q4 '21: -1.20 Q1 '22: -1.58 Q2 '22: -1.60 Q3 '22: -1.65 Q4 '22: -1.49 Q1 '23: -1.42 Q2 '23: -1.28 Q3 '23: -0.72 Q4 '23: -0.66 Q1 '24: -0.59 Q2 '24: -0.40 Q3 '24: -0.64 Q4 '24: -0.48 Q1 '25: -0.29 Q2 '25: -0.14 Q3 '25: 0.03 Q4 '25: 0.18 Q1 '26: 0.33 Q2 '26: 0.43 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.